Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects

Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects Devjit Tripathy , Priya Mohanty , Sandeep Dhindsa , Tufail Syed , Husam Ghanim , Ahmad Aljada and Paresh Dandona From the Division of Endocrinology, Diabetes and Metabolism, State University of New...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 52; no. 12; pp. 2882 - 2887
Main Authors Tripathy, Devjit, Mohanty, Priya, Dhindsa, Sandeep, Syed, Tufail, Ghanim, Husam, Aljada, Ahmad, Dandona, Paresh
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.12.2003
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects Devjit Tripathy , Priya Mohanty , Sandeep Dhindsa , Tufail Syed , Husam Ghanim , Ahmad Aljada and Paresh Dandona From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York Address correspondence and reprint requests to Paresh Dandona, MD, PhD, Diabetes-Endocrinology Center of Western New York, 3 Gates Circle, Buffalo, NY 14209. E-mail: pdandona{at}kaleidahealth.org Abstract To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-κB (NF-κB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-κB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-κB binding activity in the MNC nuclear extracts increased to 163 ± 17% and 144 ± 14% as compared with basal levels at 2 and 4 h ( P < 0.005) and remained elevated ( P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-κB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h ( P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h ( P < 0.005), whereas that by MNCs increased at 4 h ( P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 ( P < 0.05) and 4 h ( P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 ± 1.1% at baseline to 4.3 ± 1.9% and 2.7 ± 2.1% ( P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery. CRP, C-reactive protein ELISA, enzyme-linked immunosorbent assay FFA, free fatty acid ICAM, intracellular adhesion molecule IκB, inhibitor κB IKK-β, IκB kinase-β MCP-1, monocyte chemoattractant protein MIF, macrophage migration inhibitory factor MNC, mononuclear cell NF-κB, nuclear factor-κB PMN, polymorphonuclear leukocyte ROS, reactive oxygen species sICAM, soluble ICAM TBARS, thiobarbituric acid reactive substances TNF-α, tumor necrosis factor-α Footnotes Accepted September 12, 2003. Received March 5, 2003. DIABETES
AbstractList Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects Devjit Tripathy , Priya Mohanty , Sandeep Dhindsa , Tufail Syed , Husam Ghanim , Ahmad Aljada and Paresh Dandona From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York Address correspondence and reprint requests to Paresh Dandona, MD, PhD, Diabetes-Endocrinology Center of Western New York, 3 Gates Circle, Buffalo, NY 14209. E-mail: pdandona{at}kaleidahealth.org Abstract To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-κB (NF-κB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-κB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-κB binding activity in the MNC nuclear extracts increased to 163 ± 17% and 144 ± 14% as compared with basal levels at 2 and 4 h ( P < 0.005) and remained elevated ( P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-κB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h ( P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h ( P < 0.005), whereas that by MNCs increased at 4 h ( P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 ( P < 0.05) and 4 h ( P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 ± 1.1% at baseline to 4.3 ± 1.9% and 2.7 ± 2.1% ( P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery. CRP, C-reactive protein ELISA, enzyme-linked immunosorbent assay FFA, free fatty acid ICAM, intracellular adhesion molecule IκB, inhibitor κB IKK-β, IκB kinase-β MCP-1, monocyte chemoattractant protein MIF, macrophage migration inhibitory factor MNC, mononuclear cell NF-κB, nuclear factor-κB PMN, polymorphonuclear leukocyte ROS, reactive oxygen species sICAM, soluble ICAM TBARS, thiobarbituric acid reactive substances TNF-α, tumor necrosis factor-α Footnotes Accepted September 12, 2003. Received March 5, 2003. DIABETES
To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-κB (NF-κB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-κB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-κB binding activity in the MNC nuclear extracts increased to 163 ± 17% and 144 ± 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-κB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 ± 1.1% at baseline to 4.3 ± 1.9% and 2.7 ± 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery.
To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-kappaB (NF-kappaB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-kappaB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-kappaB binding activity in the MNC nuclear extracts increased to 163 +/- 17% and 144 +/- 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-kappaB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline to 4.3 +/- 1.9% and 2.7 +/- 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery.
To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-kappaB (NF-kappaB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-kappaB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-kappaB binding activity in the MNC nuclear extracts increased to 163 +/- 17% and 144 +/- 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-kappaB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline to 4.3 +/- 1.9% and 2.7 +/- 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery.To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-kappaB (NF-kappaB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-kappaB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-kappaB binding activity in the MNC nuclear extracts increased to 163 +/- 17% and 144 +/- 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-kappaB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline to 4.3 +/- 1.9% and 2.7 +/- 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery.
Audience Professional
Author Priya Mohanty
Tufail Syed
Ahmad Aljada
Devjit Tripathy
Sandeep Dhindsa
Husam Ghanim
Paresh Dandona
Author_xml – sequence: 1
  givenname: Devjit
  surname: Tripathy
  fullname: Tripathy, Devjit
  organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York
– sequence: 2
  givenname: Priya
  surname: Mohanty
  fullname: Mohanty, Priya
  organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York
– sequence: 3
  givenname: Sandeep
  surname: Dhindsa
  fullname: Dhindsa, Sandeep
  organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York
– sequence: 4
  givenname: Tufail
  surname: Syed
  fullname: Syed, Tufail
  organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York
– sequence: 5
  givenname: Husam
  surname: Ghanim
  fullname: Ghanim, Husam
  organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York
– sequence: 6
  givenname: Ahmad
  surname: Aljada
  fullname: Aljada, Ahmad
  organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York
– sequence: 7
  givenname: Paresh
  surname: Dandona
  fullname: Dandona, Paresh
  organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15327899$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/14633847$$D View this record in MEDLINE/PubMed
BookMark eNp90u-L0zAYB_AiJ97u9C8QpAgKgp350TbpyzHux2BwoIf4LmTJky0jbWeSnu6_N3M7jx3D5kWgfL6h6fO9yM66voMse4vRmFDKvmgrFxAhjCsyxmRMOCcvshFuaFNQwn6cZSOEMCkwa9h5dhHCGiFUp_UqO8dlTSkv2SgzVw4eZLR9l_cmv_YA-bWMcZtPlNUhn3V6ULDbjZNtu4ey0_ms3UjrQ_5dBjU46fOvIFW0DzZFbZffgnRxtc2_DYs1qBheZy-NdAHeHPbL7P766n56W8zvbmbTybxQdVXFwmAEaqFr4IQAVbpi0pQla7gy0ixQTRfKMKQJIUobyXhDJCk1Z5pwMCWil9nH_bEb3_8cIETR2qDAOdlBPwTBMG0qRMsE3z-D637wXfo0QXBdckxKllCxR0vpQNjO9NFLtYQOvHRpFsam1xOcnrLidZX8-IRPS0Nr1cnAp6NAMhF-x6UcQhD8Zn5si1NW9c7BEkT6i9O7Y__ucMNh0YIWG29b6bficfQJfDiANELpjJedsuHJValEvGmSa_ZO-T4ED0YoG_8WId3OOoGR2NVRPNZRVERgInZ1TFn6LPvv-P-mPu9TK7tc_bIentQp_gfRC_Kk
CODEN DIAEAZ
CitedBy_id crossref_primary_10_3390_nu13030742
crossref_primary_10_1007_s00018_011_0840_1
crossref_primary_10_1016_j_ypmed_2006_09_005
crossref_primary_10_1159_000443691
crossref_primary_10_1016_j_amjcard_2007_04_004
crossref_primary_10_1039_C8FO00888D
crossref_primary_10_2147_CLEP_S313343
crossref_primary_10_18585_inabj_v5i2_58
crossref_primary_10_1111_j_1559_4572_2009_00054_x
crossref_primary_10_2337_dc12_1912
crossref_primary_10_1016_j_obmed_2019_02_001
crossref_primary_10_3382_ps_2012_02723
crossref_primary_10_1016_j_amjcard_2023_07_010
crossref_primary_10_1016_j_biopha_2017_01_121
crossref_primary_10_1371_journal_pone_0172900
crossref_primary_10_1080_10641963_2019_1676771
crossref_primary_10_1111_j_1559_4572_2008_00013_x
crossref_primary_10_1111_j_1600_051X_2010_01580_x
crossref_primary_10_2337_dc17_2510
crossref_primary_10_1016_j_jdiacomp_2012_09_008
crossref_primary_10_1177_0022034509337479
crossref_primary_10_1016_j_metabol_2010_01_010
crossref_primary_10_1016_j_ajog_2011_03_044
crossref_primary_10_18585_inabj_v1i3_102
crossref_primary_10_1016_j_mce_2022_111836
crossref_primary_10_1007_s13679_016_0191_1
crossref_primary_10_1371_journal_pone_0016239
crossref_primary_10_1080_13880209_2018_1504972
crossref_primary_10_1073_pnas_0907995106
crossref_primary_10_2337_dc07_0817
crossref_primary_10_1155_2020_8683404
crossref_primary_10_1161_JAHA_115_002574
crossref_primary_10_3810_pgm_2013_07_2679
crossref_primary_10_1016_j_atherosclerosis_2005_06_045
crossref_primary_10_1016_j_mcna_2010_11_004
crossref_primary_10_1152_physiolgenomics_00196_2005
crossref_primary_10_4103_0366_6999_225058
crossref_primary_10_3892_ijmm_2023_5237
crossref_primary_10_12998_wjcc_v10_i26_9524
crossref_primary_10_1016_j_expneurol_2015_05_020
crossref_primary_10_1016_S1557_0843_09_80003_1
crossref_primary_10_1038_oby_2008_37
crossref_primary_10_1161_CIRCULATIONAHA_107_704080
crossref_primary_10_1038_oby_2008_39
crossref_primary_10_1186_s12937_025_01092_x
crossref_primary_10_1097_MD_0000000000022465
crossref_primary_10_1007_BF03346417
crossref_primary_10_1007_s11695_018_3550_z
crossref_primary_10_1530_JME_12_0166
crossref_primary_10_2337_dc09_S303
crossref_primary_10_1016_j_obpill_2022_100047
crossref_primary_10_1089_met_2004_2_287
crossref_primary_10_1186_cc3911
crossref_primary_10_2337_dc09_S304
crossref_primary_10_3390_nu7085292
crossref_primary_10_1111_j_1468_1331_2007_01682_x
crossref_primary_10_1248_bpb_31_1415
crossref_primary_10_1038_s41598_020_73994_1
crossref_primary_10_1161_JAHA_121_022725
crossref_primary_10_1016_j_fluid_2021_113182
crossref_primary_10_2337_dc06_2289
crossref_primary_10_1089_ars_2023_0476
crossref_primary_10_1161_01_CIR_0000158483_13093_9D
crossref_primary_10_1016_j_adengl_2012_08_024
crossref_primary_10_1038_s41385_021_00404_8
crossref_primary_10_2337_dc11_s240
crossref_primary_10_1007_s40778_021_00198_2
crossref_primary_10_1111_j_1600_051X_2011_01806_x
crossref_primary_10_1155_2012_652608
crossref_primary_10_1161_ATVBAHA_107_153239
crossref_primary_10_1016_j_metabol_2004_04_005
crossref_primary_10_1016_j_hfc_2012_06_010
crossref_primary_10_4093_dmj_2012_36_2_83
crossref_primary_10_1038_s41574_023_00893_6
crossref_primary_10_1007_s00390_010_0220_3
crossref_primary_10_1016_j_mtadv_2021_100198
crossref_primary_10_1016_j_rvsc_2015_11_013
crossref_primary_10_3390_diabetology4020015
crossref_primary_10_1016_j_tips_2010_11_006
crossref_primary_10_1152_ajpendo_00187_2018
crossref_primary_10_1089_ars_2005_7_1040
crossref_primary_10_1097_01_smj_0000209366_91803_99
crossref_primary_10_2337_dbi16_0004
crossref_primary_10_3389_fendo_2020_607240
crossref_primary_10_1016_S0140_6736_05_66378_7
crossref_primary_10_1016_j_amjcard_2006_11_003
crossref_primary_10_1111_j_1365_2265_2005_02337_x
crossref_primary_10_1152_ajpendo_00326_2005
crossref_primary_10_1016_j_bbrc_2007_01_039
crossref_primary_10_1111_j_1365_2265_2008_03519_x
crossref_primary_10_1152_ajpendo_00490_2010
crossref_primary_10_2459_JCM_0000000000001046
crossref_primary_10_1096_fj_202000495RR
crossref_primary_10_1016_S1001_9294_16_30025_6
crossref_primary_10_2337_dc09_S330
crossref_primary_10_1186_s12906_015_0598_3
crossref_primary_10_1089_met_2004_2_137
crossref_primary_10_1111_dom_12835
crossref_primary_10_1111_j_1742_4658_2007_05914_x
crossref_primary_10_1002_jcb_22173
crossref_primary_10_1111_j_1872_034X_2009_00524_x
crossref_primary_10_1016_j_jacl_2021_05_005
crossref_primary_10_2337_dc11_2399
crossref_primary_10_1515_hmbci_2018_0013
crossref_primary_10_1113_JP280651
crossref_primary_10_1186_s12986_017_0195_1
crossref_primary_10_1016_j_plefa_2010_02_012
crossref_primary_10_1111_j_2047_6310_2013_00189_x
crossref_primary_10_1093_gerona_glt081
crossref_primary_10_3390_metabo15030184
crossref_primary_10_1016_j_atherosclerosis_2017_06_010
crossref_primary_10_2165_00003495_200464002_00004
crossref_primary_10_1016_j_jacl_2007_11_001
crossref_primary_10_1111_j_1463_1326_2004_00439_x
crossref_primary_10_1177_1753944717711379
crossref_primary_10_1152_ajpendo_00566_2012
crossref_primary_10_1371_journal_pone_0130597
crossref_primary_10_1016_j_atherosclerosis_2011_09_005
crossref_primary_10_1161_CIRCULATIONAHA_108_780999
crossref_primary_10_1155_2016_5797930
crossref_primary_10_1016_j_ad_2012_08_003
crossref_primary_10_1038_srep05832
crossref_primary_10_1161_CIRCULATIONAHA_105_563213
crossref_primary_10_3390_nu14214640
crossref_primary_10_1016_j_animal_2022_100555
crossref_primary_10_1155_2016_1081657
crossref_primary_10_2337_db07_1344
crossref_primary_10_1016_j_atherosclerosis_2006_06_028
crossref_primary_10_1016_j_tripleo_2011_07_039
crossref_primary_10_1210_jc_2008_0714
crossref_primary_10_1111_j_1365_2362_2006_01734_x
crossref_primary_10_1152_ajpendo_00202_2005
crossref_primary_10_3945_jn_112_163246
crossref_primary_10_1016_j_ajog_2015_05_040
crossref_primary_10_2337_db05_1574
crossref_primary_10_1016_j_maturitas_2013_02_006
crossref_primary_10_2337_db08_1077
crossref_primary_10_1074_jbc_M706762200
crossref_primary_10_3390_foods9030368
crossref_primary_10_1016_j_metabol_2012_03_006
crossref_primary_10_1038_nature05487
crossref_primary_10_3389_fnut_2021_775216
crossref_primary_10_3390_ani11061742
crossref_primary_10_1007_s00018_020_03752_z
crossref_primary_10_1177_0961203312462756
crossref_primary_10_1016_j_atherosclerosis_2016_04_021
crossref_primary_10_1016_j_cmet_2020_12_017
crossref_primary_10_1152_ajpendo_00134_2005
crossref_primary_10_1016_j_adengl_2011_03_007
crossref_primary_10_1007_s40200_023_01367_2
crossref_primary_10_1016_S2222_1808_15_60888_X
crossref_primary_10_3390_nu11112566
crossref_primary_10_1002_dmrr_634
crossref_primary_10_1007_s00125_006_0508_9
crossref_primary_10_1177_0963689719873890
crossref_primary_10_1016_j_krcp_2013_11_002
crossref_primary_10_1371_journal_pone_0281888
crossref_primary_10_1186_1478_1336_5_1
crossref_primary_10_1002_dmrr_509
crossref_primary_10_1089_ars_2022_0016
crossref_primary_10_1007_s00059_010_3344_0
crossref_primary_10_1016_j_rbmo_2012_06_004
crossref_primary_10_3390_ijms23073828
crossref_primary_10_1007_s00125_015_3663_z
crossref_primary_10_1080_21688370_2024_2342619
crossref_primary_10_1016_j_clinbiochem_2019_01_008
crossref_primary_10_3390_metabo13070838
crossref_primary_10_1212_WNL_0000000000000275
crossref_primary_10_1002_ptr_2811
crossref_primary_10_1017_S0007114510004976
crossref_primary_10_1042_CS20110357
crossref_primary_10_1161_CIRCRESAHA_119_315833
crossref_primary_10_4103_ijmr_IJMR_1807_16
crossref_primary_10_1080_13880209_2020_1790619
crossref_primary_10_1016_j_cyto_2008_06_014
crossref_primary_10_1097_00042737_200411000_00001
crossref_primary_10_1161_CIR_0b013e3182a88099
crossref_primary_10_1016_j_metabol_2016_09_001
crossref_primary_10_1007_s11357_020_00313_x
crossref_primary_10_1016_j_jphotobiol_2016_09_017
crossref_primary_10_1016_j_pcad_2014_09_005
crossref_primary_10_1590_0001_3765201920180547
crossref_primary_10_1152_ajpendo_00624_2006
crossref_primary_10_2337_db15_0244
crossref_primary_10_1152_ajpendo_00039_2017
crossref_primary_10_1111_j_1742_7843_2009_00448_x
crossref_primary_10_1016_j_freeradbiomed_2012_05_026
crossref_primary_10_1155_2017_9067049
crossref_primary_10_1016_j_krcp_2015_01_001
crossref_primary_10_1002_oby_22602
crossref_primary_10_1038_ismej_2012_153
crossref_primary_10_3389_fendo_2022_854931
crossref_primary_10_1096_fj_08_124784
crossref_primary_10_1016_j_bbrc_2007_04_092
crossref_primary_10_1139_bcb_2022_0266
crossref_primary_10_1007_s00125_013_3111_x
crossref_primary_10_5717_jenb_2014_18_1_51
crossref_primary_10_1532_HSF98_20101017
crossref_primary_10_1111_jgs_16793
crossref_primary_10_4158_EP12331_OR
crossref_primary_10_1016_j_mehy_2014_08_018
crossref_primary_10_1016_j_diabet_2007_10_009
crossref_primary_10_1007_s00125_009_1573_7
crossref_primary_10_1155_2018_8168717
crossref_primary_10_1152_ajpheart_00038_2018
crossref_primary_10_1186_1476_511X_10_53
crossref_primary_10_1093_aje_kwac044
crossref_primary_10_18663_tjcl_687043
crossref_primary_10_1111_bcp_12854
crossref_primary_10_1155_2013_564961
crossref_primary_10_1111_acel_12416
crossref_primary_10_1111_j_1464_5491_2005_01656_x
crossref_primary_10_1183_09031936_00050410
crossref_primary_10_1186_1475_2840_9_73
crossref_primary_10_1007_s11906_010_0114_6
crossref_primary_10_1016_j_jpeds_2007_03_056
crossref_primary_10_1016_j_metabol_2009_06_005
crossref_primary_10_1016_j_exger_2018_04_016
crossref_primary_10_1210_jendso_bvaa049
crossref_primary_10_1016_j_fct_2006_03_004
crossref_primary_10_1007_s11892_005_0064_6
crossref_primary_10_3390_antiox9070618
crossref_primary_10_1016_j_ecl_2017_10_005
crossref_primary_10_1016_j_ijcard_2010_07_019
crossref_primary_10_1016_j_lfs_2018_08_034
crossref_primary_10_1155_2015_202406
crossref_primary_10_2337_db10_0778
crossref_primary_10_1016_j_bbalip_2006_06_003
crossref_primary_10_1016_j_jhep_2005_10_033
crossref_primary_10_1155_2022_6007233
crossref_primary_10_1210_en_2006_1068
crossref_primary_10_1002_dmrr_70004
crossref_primary_10_1111_j_1440_1746_2010_06561_x
crossref_primary_10_3389_fnhum_2020_602360
crossref_primary_10_3390_life14091082
crossref_primary_10_1053_j_gastro_2007_03_059
crossref_primary_10_1007_s40618_017_0799_3
crossref_primary_10_1053_j_ajkd_2020_11_030
crossref_primary_10_1016_j_freeradbiomed_2005_06_018
crossref_primary_10_1177_1753944707082662
crossref_primary_10_1016_j_vph_2015_05_006
crossref_primary_10_1111_dom_14206
crossref_primary_10_1371_journal_pone_0248073
crossref_primary_10_1007_s10237_017_1000_9
crossref_primary_10_3390_plants12203583
crossref_primary_10_3390_ani10091499
crossref_primary_10_1053_j_semtcvs_2006_06_003
crossref_primary_10_1016_S1557_0843_08_80035_8
crossref_primary_10_1016_j_soard_2011_09_026
crossref_primary_10_1038_s41387_024_00302_5
crossref_primary_10_1016_j_jacl_2020_06_005
crossref_primary_10_1002_jpen_2507
crossref_primary_10_1016_j_freeradbiomed_2004_12_010
crossref_primary_10_3810_psm_2014_02_2042
crossref_primary_10_1136_bmjopen_2018_028652
crossref_primary_10_1016_j_surg_2011_09_038
crossref_primary_10_1161_01_ATV_0000200226_53994_09
crossref_primary_10_1016_j_bbrc_2006_05_170
crossref_primary_10_1002_dmrr_1183
crossref_primary_10_1016_j_atherosclerosis_2009_10_032
crossref_primary_10_2337_dc15_1518
crossref_primary_10_1186_gm313
crossref_primary_10_1016_j_cimid_2011_01_004
crossref_primary_10_1186_s12865_016_0184_6
crossref_primary_10_3390_biomedicines13040779
crossref_primary_10_2337_dc10_0929
crossref_primary_10_1186_s12933_025_02599_7
crossref_primary_10_1152_ajpendo_00010_2005
crossref_primary_10_1210_jc_2009_1387
crossref_primary_10_1590_S0004_27302008000600007
crossref_primary_10_2337_dc07_1338
crossref_primary_10_1161_CIRCRESAHA_122_320334
crossref_primary_10_1042_BCJ20190468
crossref_primary_10_1038_oby_2010_291
crossref_primary_10_1507_endocrj_EJ16_0233
crossref_primary_10_1016_j_ahj_2004_03_060
crossref_primary_10_1210_jc_2005_0223
crossref_primary_10_1097_MCC_0b013e32826388a1
crossref_primary_10_1177_0003319710371616
crossref_primary_10_1002_bies_202400154
crossref_primary_10_3390_immuno4010006
crossref_primary_10_1210_en_2012_1720
crossref_primary_10_1016_j_smim_2015_05_002
crossref_primary_10_1111_ggi_14131
crossref_primary_10_1016_j_atherosclerosis_2020_12_016
crossref_primary_10_1161_CIRCHEARTFAILURE_113_000521
crossref_primary_10_1111_dom_13144
crossref_primary_10_1016_j_heliyon_2024_e30329
crossref_primary_10_1210_jc_2006_2491
crossref_primary_10_2337_db09_0232
crossref_primary_10_1016_j_nut_2007_10_018
crossref_primary_10_1016_j_cell_2013_01_041
crossref_primary_10_1210_jc_2006_2130
crossref_primary_10_1016_j_amjcard_2007_07_014
crossref_primary_10_1210_jc_2006_0195
crossref_primary_10_1136_bmjdrc_2018_000632
crossref_primary_10_1186_1472_6882_8_39
crossref_primary_10_1007_s00380_010_0016_1
crossref_primary_10_1161_01_CIR_0000142055_53122_FA
crossref_primary_10_1002_biof_1277
crossref_primary_10_1038_s12276_018_0147_5
crossref_primary_10_1111_jphp_12223
crossref_primary_10_3892_mmr_2024_13219
crossref_primary_10_1517_14656566_6_13_2209
crossref_primary_10_1152_ajpendo_00300_2020
crossref_primary_10_1161_01_ATV_0000187465_55507_85
crossref_primary_10_1007_s11756_022_01112_9
crossref_primary_10_1016_j_metabol_2006_04_016
crossref_primary_10_1016_j_diabet_2010_12_005
crossref_primary_10_1017_S0029665111000073
crossref_primary_10_1038_ijo_2009_242
crossref_primary_10_3803_jkes_2006_21_6_448
crossref_primary_10_1016_j_diabres_2011_10_025
crossref_primary_10_1210_jc_2009_0027
crossref_primary_10_2147_DMSO_S264876
crossref_primary_10_1007_s00125_013_2964_3
crossref_primary_10_1111_eci_13737
crossref_primary_10_2337_dc14_1919
crossref_primary_10_1038_oby_2009_179
crossref_primary_10_2174_1871530323666230309144825
crossref_primary_10_1016_j_lfs_2013_05_002
crossref_primary_10_1155_2014_479587
crossref_primary_10_1155_2016_6757154
crossref_primary_10_1038_oby_2008_494
crossref_primary_10_1210_jc_2004_1795
crossref_primary_10_1016_j_freeradbiomed_2010_08_015
crossref_primary_10_1111_obr_13403
crossref_primary_10_1186_1475_2840_9_9
crossref_primary_10_2337_diacare_27_9_2272
crossref_primary_10_1210_jc_2008_1590
crossref_primary_10_3389_fphar_2020_588449
crossref_primary_10_1111_j_1365_2362_2004_01383_x
crossref_primary_10_1155_2017_1909258
crossref_primary_10_1016_j_joms_2011_01_012
crossref_primary_10_1080_01480545_2024_2405830
crossref_primary_10_1038_s41598_023_28329_1
crossref_primary_10_1016_S0214_9168_08_72584_1
crossref_primary_10_3892_ijmm_2020_4479
crossref_primary_10_1016_j_arr_2024_102503
crossref_primary_10_1007_s00125_007_0861_3
crossref_primary_10_1371_journal_ppat_1004750
crossref_primary_10_2174_1871530322666220215110041
crossref_primary_10_1021_jf402966r
crossref_primary_10_1111_j_1872_034X_2007_00215_x
crossref_primary_10_1016_j_trsl_2021_05_006
crossref_primary_10_21215_kjfp_2022_12_3_144
crossref_primary_10_18632_oncotarget_26937
crossref_primary_10_1042_CS20080253
crossref_primary_10_1007_s13410_018_0626_1
crossref_primary_10_1007_s00592_008_0038_7
crossref_primary_10_1016_j_abb_2008_02_019
crossref_primary_10_2337_db08_1512
crossref_primary_10_1139_Y07_026
crossref_primary_10_18705_1607_419X_2008_14_2_116_124
crossref_primary_10_1089_met_2004_2_2
crossref_primary_10_1016_j_biopha_2018_08_129
crossref_primary_10_3109_15376516_2012_666648
crossref_primary_10_1126_sciadv_ads5963
crossref_primary_10_1007_s11892_010_0115_5
crossref_primary_10_2337_db14_1481
crossref_primary_10_1016_j_exer_2019_107737
crossref_primary_10_3390_ijms25126776
crossref_primary_10_1089_met_2004_2_105
crossref_primary_10_1016_j_ijbiomac_2007_11_002
crossref_primary_10_1007_s11940_015_0344_7
crossref_primary_10_1016_j_febslet_2014_09_024
crossref_primary_10_1177_0885066614528083
crossref_primary_10_1155_2015_620258
crossref_primary_10_1016_j_clineuro_2007_10_016
crossref_primary_10_2337_diacare_27_10_2509
crossref_primary_10_1053_j_jvca_2012_09_013
crossref_primary_10_18632_oncotarget_3202
crossref_primary_10_1016_j_amjcard_2014_06_012
crossref_primary_10_1093_bjd_ljac107
crossref_primary_10_1016_j_jnutbio_2009_03_004
crossref_primary_10_1007_s12020_023_03433_4
crossref_primary_10_1111_jdi_12678
crossref_primary_10_1074_jbc_M110_193037
crossref_primary_10_3390_biom13020241
crossref_primary_10_1111_j_1524_6175_2005_04617_x
crossref_primary_10_3844_ajbbsp_2010_103_110
crossref_primary_10_2337_db08_1775
crossref_primary_10_1016_j_jcte_2015_02_004
crossref_primary_10_1161_01_CIR_0000165070_46111_9F
crossref_primary_10_1016_j_ejphar_2013_05_014
crossref_primary_10_1210_jc_2012_1318
crossref_primary_10_12659_MSM_883206
crossref_primary_10_1016_j_ad_2011_03_010
crossref_primary_10_2337_dci21_0003
crossref_primary_10_3390_nu15020257
crossref_primary_10_1038_srep06697
crossref_primary_10_1186_s12920_020_00767_0
crossref_primary_10_1016_j_cca_2016_05_006
crossref_primary_10_1186_s12950_017_0150_y
crossref_primary_10_1007_s11154_012_9235_3
crossref_primary_10_1007_s43440_019_00013_0
crossref_primary_10_1089_jmf_2014_3265
crossref_primary_10_1161_01_ATV_0000122852_22604_78
crossref_primary_10_1038_s41598_017_01603_9
crossref_primary_10_1007_s00125_021_05596_z
crossref_primary_10_1210_jc_2012_1544
crossref_primary_10_3390_ph15101278
crossref_primary_10_1126_scitranslmed_3000850
crossref_primary_10_1186_1475_2840_10_61
crossref_primary_10_1016_j_atherosclerosis_2007_01_003
crossref_primary_10_1186_s12933_014_0159_y
crossref_primary_10_1097_MCO_0b013e3281e38774
crossref_primary_10_1007_s12272_013_0023_8
crossref_primary_10_2174_1381612826666200203120540
crossref_primary_10_3390_ijms23020786
crossref_primary_10_1016_j_yfrne_2021_100972
crossref_primary_10_1096_fj_202300396R
crossref_primary_10_1007_s11936_006_0045_3
crossref_primary_10_4081_pr_2009_e1
crossref_primary_10_1016_j_atherosclerosis_2010_05_028
crossref_primary_10_1210_er_2008_0024
crossref_primary_10_1016_j_yexcr_2017_05_020
crossref_primary_10_1007_s11154_012_9232_6
crossref_primary_10_1186_1472_6823_9_8
crossref_primary_10_3109_13813455_2011_562513
crossref_primary_10_1152_ajpendo_00507_2007
crossref_primary_10_1002_dmrr_1195
crossref_primary_10_1016_j_metabol_2010_02_005
crossref_primary_10_3390_metabo13010087
crossref_primary_10_1097_CCE_0000000000000977
crossref_primary_10_5402_2011_519371
crossref_primary_10_1016_j_prostaglandins_2020_106454
crossref_primary_10_1002_pmic_201000544
crossref_primary_10_1016_j_metabol_2006_06_001
crossref_primary_10_1530_JME_11_0082
crossref_primary_10_1111_jch_13443
crossref_primary_10_1016_j_diabres_2007_10_007
crossref_primary_10_1097_MOL_0b013e328012b627
crossref_primary_10_3390_antiox13010087
crossref_primary_10_1038_s41401_020_0493_4
crossref_primary_10_3390_nu14010203
crossref_primary_10_18705_1607_419X_2010_16_1_93_103
crossref_primary_10_1016_j_krcp_2014_10_007
crossref_primary_10_1017_S0029665107005320
crossref_primary_10_1186_s12979_018_0119_6
crossref_primary_10_1093_toxres_tfab014
crossref_primary_10_3390_nu11020384
crossref_primary_10_1152_physrev_00034_2018
crossref_primary_10_2337_diabetes_53_8_2079
crossref_primary_10_1038_mt_2016_160
crossref_primary_10_3389_fphar_2024_1364881
crossref_primary_10_1007_s11892_011_0190_2
crossref_primary_10_1016_j_jdiacomp_2006_10_009
crossref_primary_10_1111_j_1463_1326_2008_00867_x
crossref_primary_10_1196_annals_1367_007
crossref_primary_10_1089_ars_2014_6126
crossref_primary_10_1016_j_bbrc_2008_08_115
crossref_primary_10_1002_fsn3_4
crossref_primary_10_3390_jcm9072257
crossref_primary_10_2337_dc10_2345
crossref_primary_10_1016_j_plipres_2021_101142
crossref_primary_10_1152_ajpheart_00291_2014
crossref_primary_10_1093_cvr_cvaa009
crossref_primary_10_1186_1743_7075_8_16
crossref_primary_10_1002_mco2_516
crossref_primary_10_1051_ject_201345242
crossref_primary_10_2174_0929867330666230510101150
Cites_doi 10.1152/ajpregu.2000.279.3.R1043
10.1016/S0026-0495(98)90113-5
10.1084/jem.179.6.1895
10.1210/jcem.86.7.7623
10.1038/23948
10.1172/JCI5001
10.1007/s00125-002-0896-4
10.1126/science.1061620
10.1172/JCI118504
10.1210/jcem.86.3.7309
10.2337/diabetes.50.7.1612
10.1210/jc.86.7.3130
10.1172/JCI119636
10.1093/ajcp/97.4.566
10.1210/jc.86.7.3250
10.1172/JCI117936
10.4158/EP.7.1.44
10.1093/nar/19.9.2499
10.1161/01.CIR.96.10.3287
10.1210/jcem.83.8.5026
10.1385/0-89603-472-0:107
10.2337/diabetes.51.7.2005
10.1007/BF03401892
10.1042/bj2420103
10.1161/01.HYP.36.5.866
10.2337/diabetes.49.7.1231
10.2337/diabetes.48.6.1270
10.1073/pnas.95.19.11383
ContentType Journal Article
Copyright 2004 INIST-CNRS
COPYRIGHT 2003 American Diabetes Association
COPYRIGHT 2003 American Diabetes Association
Copyright American Diabetes Association Dec 2003
Copyright_xml – notice: 2004 INIST-CNRS
– notice: COPYRIGHT 2003 American Diabetes Association
– notice: COPYRIGHT 2003 American Diabetes Association
– notice: Copyright American Diabetes Association Dec 2003
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
8GL
3V.
7RV
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M1P
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
S0X
7X8
DOI 10.2337/diabetes.52.12.2882
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: High School
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest eLibrary (NC LIVE)
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection (UHCL Subscription)
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef
Research Library Prep
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 2887
ExternalDocumentID 489990991
A111145865
14633847
15327899
10_2337_diabetes_52_12_2882
diabetes_52_12_2882
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID -
08R
0R
1AW
29F
2WC
3V.
4.4
53G
55
5GY
5RE
5RS
5VS
7RV
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
8GL
8R4
8R5
AAQQT
AAWTL
AAYEP
AAYJJ
ABFLS
ABOCM
ABPTK
ABUWG
ACDCL
ACGOD
ACPRK
ADACO
ADBBV
ADBIT
AENEX
AFFNX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBAFP
BBNVY
BCR
BCU
BEC
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BVXVI
C1A
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EX3
F5P
FRP
FYUFA
GICCO
GJ
GNUQQ
GUQSH
GX1
H13
HCIFZ
HZ
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
J5H
K-O
K9-
KM
KQ8
L7B
LK8
M0R
M1P
M2O
M2P
M2Q
M5
M7P
MBDVC
O0-
O9-
OB3
OBH
OK1
OVD
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
RHF
RHI
RPM
S0X
SJFOW
SJN
SV3
TDI
WH7
WOQ
WOW
X7M
XZ
ZA5
ZGI
ZXP
ZY1
---
.55
.GJ
.XZ
08P
0R~
18M
354
6PF
AAFWJ
AAKAS
AAYOK
AAYXX
ACGFO
ADZCM
AEGXH
AERZD
AIAGR
AIZAD
ALIPV
BTFSW
CCPQU
CITATION
EMOBN
HMCUK
HZ~
ITC
K2M
M5~
N4W
NAPCQ
OHH
PHGZM
PHGZT
TEORI
TR2
UKHRP
VVN
W8F
YFH
YHG
YOC
~KM
1CY
ADGHP
AI.
H~9
IQODW
MVM
O5R
O5S
PJZUB
PPXIY
PQGLB
VH1
XOL
YQJ
AFHIN
CGR
CUY
CVF
ECM
EIF
NPM
PKN
PMFND
7XB
8FK
K9.
PKEHL
Q9U
7X8
ID FETCH-LOGICAL-c655t-f10ecbd6e822e3cd57af44798cfafb063bcf70d222cdfa7892a24d87d28ef403
IEDL.DBID 7X7
ISSN 0012-1797
IngestDate Fri Jul 11 12:25:05 EDT 2025
Fri Jul 25 19:29:12 EDT 2025
Fri Jun 13 00:47:09 EDT 2025
Tue Jun 10 21:25:03 EDT 2025
Fri Jun 27 04:10:54 EDT 2025
Tue Jun 10 19:06:25 EDT 2025
Wed Feb 19 02:32:51 EST 2025
Mon Jul 21 09:16:24 EDT 2025
Tue Jul 01 04:24:24 EDT 2025
Thu Apr 24 23:05:27 EDT 2025
Fri Jan 15 19:45:49 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Endocrinopathy
Human
Reactivity
Diabetes mellitus
Lipids
Inflammation
Free fatty acid
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c655t-f10ecbd6e822e3cd57af44798cfafb063bcf70d222cdfa7892a24d87d28ef403
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://diabetesjournals.org/diabetes/article-pdf/52/12/2882/371392/db1203002882.pdf
PMID 14633847
PQID 216481247
PQPubID 34443
PageCount 6
ParticipantIDs gale_incontextgauss_8GL_A111145865
proquest_journals_216481247
crossref_citationtrail_10_2337_diabetes_52_12_2882
gale_infotracgeneralonefile_A111145865
gale_incontextcollege_GICCO_A111145865
pascalfrancis_primary_15327899
highwire_diabetes_diabetes_52_12_2882
crossref_primary_10_2337_diabetes_52_12_2882
proquest_miscellaneous_71395034
gale_infotracacademiconefile_A111145865
pubmed_primary_14633847
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-12-01
PublicationDateYYYYMMDD 2003-12-01
PublicationDate_xml – month: 12
  year: 2003
  text: 2003-12-01
  day: 01
PublicationDecade 2000
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2003
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References 2022031207073279900_R28
2022031207073279900_R27
2022031207073279900_R11
2022031207073279900_R10
2022031207073279900_R15
2022031207073279900_R14
2022031207073279900_R13
2022031207073279900_R12
2022031207073279900_R2
2022031207073279900_R19
2022031207073279900_R1
2022031207073279900_R18
2022031207073279900_R17
2022031207073279900_R16
2022031207073279900_R9
2022031207073279900_R8
2022031207073279900_R7
2022031207073279900_R6
2022031207073279900_R5
2022031207073279900_R4
2022031207073279900_R3
2022031207073279900_R22
2022031207073279900_R21
2022031207073279900_R20
2022031207073279900_R26
2022031207073279900_R25
2022031207073279900_R24
2022031207073279900_R23
References_xml – ident: 2022031207073279900_R25
  doi: 10.1152/ajpregu.2000.279.3.R1043
– ident: 2022031207073279900_R12
  doi: 10.1016/S0026-0495(98)90113-5
– ident: 2022031207073279900_R27
  doi: 10.1084/jem.179.6.1895
– ident: 2022031207073279900_R18
  doi: 10.1210/jcem.86.7.7623
– ident: 2022031207073279900_R5
  doi: 10.1038/23948
– ident: 2022031207073279900_R2
  doi: 10.1172/JCI5001
– ident: 2022031207073279900_R26
  doi: 10.1007/s00125-002-0896-4
– ident: 2022031207073279900_R6
  doi: 10.1126/science.1061620
– ident: 2022031207073279900_R9
  doi: 10.1172/JCI118504
– ident: 2022031207073279900_R24
  doi: 10.1210/jcem.86.3.7309
– ident: 2022031207073279900_R1
  doi: 10.2337/diabetes.50.7.1612
– ident: 2022031207073279900_R8
  doi: 10.1210/jc.86.7.3130
– ident: 2022031207073279900_R3
  doi: 10.1172/JCI119636
– ident: 2022031207073279900_R13
  doi: 10.1093/ajcp/97.4.566
– ident: 2022031207073279900_R7
  doi: 10.1210/jc.86.7.3250
– ident: 2022031207073279900_R10
  doi: 10.1172/JCI117936
– ident: 2022031207073279900_R21
  doi: 10.4158/EP.7.1.44
– ident: 2022031207073279900_R15
  doi: 10.1093/nar/19.9.2499
– ident: 2022031207073279900_R28
  doi: 10.1161/01.CIR.96.10.3287
– ident: 2022031207073279900_R11
  doi: 10.1210/jcem.83.8.5026
– ident: 2022031207073279900_R16
  doi: 10.1385/0-89603-472-0:107
– ident: 2022031207073279900_R23
  doi: 10.2337/diabetes.51.7.2005
– ident: 2022031207073279900_R19
  doi: 10.1007/BF03401892
– ident: 2022031207073279900_R14
  doi: 10.1042/bj2420103
– ident: 2022031207073279900_R17
  doi: 10.1161/01.HYP.36.5.866
– ident: 2022031207073279900_R4
  doi: 10.2337/diabetes.49.7.1231
– ident: 2022031207073279900_R22
  doi: 10.2337/diabetes.48.6.1270
– ident: 2022031207073279900_R20
  doi: 10.1073/pnas.95.19.11383
SSID ssj0006060
Score 2.3548408
Snippet Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects Devjit Tripathy , Priya Mohanty , Sandeep Dhindsa ,...
To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and...
SourceID proquest
gale
pubmed
pascalfrancis
crossref
highwire
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2882
SubjectTerms Adult
Anticoagulants
Associated diseases and complications
Biological and medical sciences
Blood
Brachial Artery - physiology
Cytokines
Diabetes
Diabetes mellitus
Diabetes research
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Fatty acid metabolism
Fatty acids
Fatty Acids, Nonesterified - blood
Female
Humans
Inflammation
Inflammation - etiology
Insulin - blood
Insulin resistance
Kinases
Leukocytes
Lipids
Male
Medical sciences
Monocytes - metabolism
Neutrophils - metabolism
NF-kappa B - metabolism
Oxidative stress
Physiological aspects
Plasma
Reactive Oxygen Species - metabolism
Reference Values
Thiobarbituric Acid Reactive Substances - metabolism
Transcription Factor RelA
Triglycerides - blood
Tumor necrosis factor-TNF
Vasodilation
Veins & arteries
Title Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects
URI http://diabetes.diabetesjournals.org/content/52/12/2882.abstract
https://www.ncbi.nlm.nih.gov/pubmed/14633847
https://www.proquest.com/docview/216481247
https://www.proquest.com/docview/71395034
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglRAXxJtQWCwE5ULaxLFj54TKakuFaEGoSHuzHD-qSlW2bLKH_ntm1smuIpVedg-ZRHFmPP48nvmGkA-VrKuKCZ967sqUm7xMVW5sCpsJ42vlrFyHBk7PypM__PtczPvcnLZPqxx84tpRu4XFGPkhA1yPi5H8cv03xaZReLjad9C4T3aRuQyNWs43-60MsHmsQMkZsnDKSDrEikIeDoHNA8EwGsiUYqOFaXDPA2cwpkyaFr5aiO0u_o9H1-vS8WPyqAeU9ChawBNyzzdPyYPT_sj8GQmzKx_DrnQRaFh6T4Ppuhtq7KVrKWzJQbn4H8A2Yh0jNY2jWD55uWzpkKpKAV3a2GoChGmsn7yh7arGSE77nJwfz86nJ2nfXCG1pRBdGvLM29qVHhCCL6wT0gTOZaVsMKEG4FLbIDMH8MG6YKSqmGHcKemY8oFnxQuy0ywa_4pQFvJSYDi1tHBBSuVLmNWZqyVYAZc2IWz4sNr2xOPY_-JKwwYEtaEHbWjBdM40aiMhnzc3XUfejbvF91FjGhktGkyZsTHsomHI05_6CBcGLlQpEvJ-LHhhVm2r1bcfI6FPvVBYwJta05cqwHiRLWskuT-SvIhc4bcJfhxsafv-tw5kMjK07eBFgUXLVUL2BsvTvbtp9WZyJOTd5ir4CTz8MY1frFotAeqLrOAJeRnNdftkXhYFgJTXdz55jzyMeYyYyfOG7HTLlX8LeKyrJ-tZB79qmk_I7tfZ2a_f_wCkEjb5
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLfGkIAL4psw2CzExoWwxrHj5IDQVDY61o5LkXazHH9MlaZ0NK1Q_yf-SN6rk1aRxm479ZBXK877-X35fRDyoZBlUTDhYsdtFnOdZHGeaBODM6FdmVsjV6GB0Xk2-MV_XIiLLfK3rYXBtMpWJq4EtZ0ajJEfMrDrURnJr9e_YxwahZer7QSNgIozt_wDHlv95fQbsHefsZPjcX8QN0MFYpMJMY990nOmtJkDzehSY4XUnnNZ5MZrX4LCLo2XPQtq01ivZV4wzbjNpWW587yXwrL3yH2ewsHEuvT-JqEEXIFQ8JIwbPopQ48jBpSHbRz1s2AYfGR5zjp6sNUGbYtizNDUNTDJh-ka_zd_V2rw5Al53Niv9CgA7inZctUz8mDU3NA_J_74yoUoL5166mfOUa_n8yXVZmJrOqksYAl_PUAxlE1SXVmK1ZqTWU3bzFgKxqwJky2AmIZyzSWtFyUGjuoXZHwXn_0l2a6mlXtNKPNJJjB6mxl4IGXuMhAiPVtKAB2XJiKs_bDKNH3OcdzGlQJ_B7mhWm4owVTCFHIjIp_Wf7oObT5uJz9AjilsoFFhho4JUR4FW-7_VEeoh7jIMxGR913CS72oa5V_H3aIPjZEfgpvanRTGQH7xeZcHcqDDuVlaE1-E-F-i6XN-9-4kd0O0DabFynWSBcR2WmRpxrpVqv1WYzI3vopiCW8a9KVmy5qJcGzEL2UR-RVgOtmZZ6lKdhEb25deY88HIxHQzU8PT_bIY9CCiUmEb0l2_PZwr0DU3Be7q5OICXqjk_8P-Ckcok
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcUHmbQrtCtFwwidde7_qAUJU2tPQBhyL1tlrvo4pUOW2cCOWf8fOYydqJLJXeesrBk5XX881jZ-dByMdClEXBuItdZvM400key0SbGA4T2pXSGrEIDZyd50e_sx-X_HKN_G1rYTCtstWJC0VtxwZj5D0Gfj0aI9HzTVbEr4Pht5vbGAdI4UVrO00jIOTEzf_A6a3-enwArN5lbHh4MTiKmwEDsck5n8Y-6TtT2tyBlXSpsVxon2WikMZrX4LxLo0XfQsm1FivhSyYZpmVwjLpfNZPYdlH5LFIhUQJk4NVcgkcC0LxS8KwAagI_Y5YmopeG1P9whkGIpmUrGMTW8vQtivGbE1dA8N8mLTxf1d4YRKHm-Rp48vS_QC-Z2TNVc_JxllzW_-C-MNrFyK-dOypnzhHvZ5O51Sbka3pqLKAK_z1AMtQQkl1ZSlWbo4mNW2zZCk4tiZMuQBiGko357SelRhEql-Si4f47K_IejWu3BtCmU9yjpHc3MADIaTLQaH0bSkAgJkwEWHth1Wm6XmOozeuFZx9kBuq5YbiTCVMITci8nn5p5vQ8uN-8j3kmMJmGhXi0oSIj4ItD36qfbRJGZc5j8iHLuGVntW1kt9PO0SfGiI_hjc1uqmSgP1io64O5V6H8iq0Kb-LcLfF0ur979zIdgdoq83zFOuli4hstchTjaar1VIuI7KzfAoqCu-ddOXGs1oJOGXwfppF5HWA62rlLE9T8I_e3rvyDtkAWVenx-cnW-RJyKbEfKJ3ZH06mbn34BVOy-2FAFKiHljg_wEfvna_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevation+of+free+fatty+acids+induces+inflammation+and+impairs+vascular+reactivity+in+healthy+subjects&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Tripathy%2C+Devjit&rft.au=Mohanty%2C+Priya&rft.au=Dhindsa%2C+Sandeep&rft.au=Syed%2C+Tufail&rft.date=2003-12-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.volume=52&rft.issue=12&rft.spage=2882&rft_id=info:doi/10.2337%2Fdiabetes.52.12.2882&rft.externalDocID=A111145865
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon